Vanguard Group
ANGO icon

Vanguard Group’s AngioDynamics ANGO Stock Holding History

Vanguard Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$31.3M Buy
2,436,833
+72,687
+3% +$897K ﹤0.01% 2417
2025
Q3 		$26.4M Sell
2,364,146
-125,090
-5% -$1.21M ﹤0.01% 2483
2025
Q2 		$24.7M Sell
2,489,236
-3,327
-0.1% -$32.6K ﹤0.01% 2468
2025
Q1 		$23.4M Buy
2,492,563
+199,944
+9% +$2.1M ﹤0.01% 2438
2024
Q4 		$21M Buy
2,292,619
+2,764
+0.1% +$20.3K ﹤0.01% 2565
2024
Q3 		$17.8M Buy
2,289,855
+100,405
+5% +$725K ﹤0.01% 2644
2024
Q2 		$13.2M Sell
2,189,450
-43,405
-2% -$268K ﹤0.01% 2766
2024
Q1 		$13.1M Sell
2,232,855
-35,606
-2% -$212K ﹤0.01% 2813
2023
Q4 		$17.8M Buy
2,268,461
+136,323
+6% +$946K ﹤0.01% 2648
2023
Q3 		$15.6M Sell
2,132,138
-591,939
-22% -$4.93M ﹤0.01% 2656
2023
Q2 		$28.4M Sell
2,724,077
-31,594
-1% -$304K ﹤0.01% 2438
2023
Q1 		$28.5M Sell
2,755,671
-26,122
-0.9% -$334K ﹤0.01% 2438
2022
Q4 		$38.3M Buy
2,781,793
+192,470
+7% +$2.68M ﹤0.01% 2318
2022
Q3 		$53M Buy
2,589,323
+38,898
+2% +$854K ﹤0.01% 2153
2022
Q2 		$49.4M Buy
2,550,425
+1,353
+0.1% +$27.7K ﹤0.01% 2197
2022
Q1 		$54.9M Sell
2,549,072
-12,152
-0.5% -$276K ﹤0.01% 2256
2021
Q4 		$70.6M Buy
2,561,224
+28,108
+1% +$776K ﹤0.01% 2160
2021
Q3 		$65.7M Buy
2,533,116
+7,669
+0.3% +$205K ﹤0.01% 2218
2021
Q2 		$68.5M Buy
2,525,447
+131,090
+5% +$3.2M ﹤0.01% 2202
2021
Q1 		$56M Buy
2,394,357
+163,234
+7% +$3.3M ﹤0.01% 2254
2020
Q4 		$34.2M Sell
2,231,123
-123,893
-5% -$1.57M ﹤0.01% 2385
2020
Q3 		$28.4M Sell
2,355,016
-108,833
-4% -$1.03M ﹤0.01% 2293
2020
Q2 		$25.1M Buy
2,463,849
+79,301
+3% +$817K ﹤0.01% 2308
2020
Q1 		$24.9M Buy
2,384,548
+13,849
+0.6% +$174K ﹤0.01% 2192
2019
Q4 		$38M Buy
2,370,699
+41,575
+2% +$635K ﹤0.01% 2230
2019
Q3 		$42.9M Buy
2,329,124
+31,898
+1% +$624K ﹤0.01% 2141
2019
Q2 		$45.2M Sell
2,297,226
-735
-0% -$15K ﹤0.01% 2157
2019
Q1 		$52.5M Buy
2,297,961
+28,270
+1% +$614K ﹤0.01% 2060
2018
Q4 		$45.7M Buy
2,269,691
+125,400
+6% +$2.59M ﹤0.01% 2070
2018
Q3 		$46.6M Buy
2,144,291
+42,134
+2% +$936K ﹤0.01% 2176
2018
Q2 		$46.8M Buy
2,102,157
+14,654
+0.7% +$300K ﹤0.01% 2161
2018
Q1 		$36M Buy
2,087,503
+48,904
+2% +$816K ﹤0.01% 2235
2017
Q4 		$33.9M Buy
2,038,599
+19,034
+0.9% +$325K ﹤0.01% 2266
2017
Q3 		$34.5M Buy
2,019,565
+81,450
+4% +$1.37M ﹤0.01% 2234
2017
Q2 		$31.4M Buy
1,938,115
+243,825
+14% +$3.85M ﹤0.01% 2256
2017
Q1 		$29.4M Buy
1,694,290
+116,814
+7% +$1.95M ﹤0.01% 2263
2016
Q4 		$26.6M Buy
1,577,476
+159,810
+11% +$2.67M ﹤0.01% 2286
2016
Q3 		$24.9M Buy
1,417,666
+142,833
+11% +$2.32M ﹤0.01% 2266
2016
Q2 		$18.3M Sell
1,274,833
-13,556
-1% -$169K ﹤0.01% 2363
2016
Q1 		$15.8M Buy
1,288,389
+34,088
+3% +$377K ﹤0.01% 2391
2015
Q4 		$15.2M Buy
1,254,301
+29,697
+2% +$366K ﹤0.01% 2421
2015
Q3 		$16.2M Buy
1,224,604
+32,119
+3% +$485K ﹤0.01% 2389
2015
Q2 		$19.6M Buy
1,192,485
+21,236
+2% +$353K ﹤0.01% 2367
2015
Q1 		$20.8M Buy
1,171,249
+78,460
+7% +$1.46M ﹤0.01% 2303
2014
Q4 		$20.8M Buy
1,092,789
+151,804
+16% +$2.57M ﹤0.01% 2221
2014
Q3 		$12.9M Buy
940,985
+18,905
+2% +$270K ﹤0.01% 2384
2014
Q2 		$15.1M Buy
922,080
+21,416
+2% +$310K ﹤0.01% 2328
2014
Q1 		$14.2M Buy
900,664
+41,689
+5% +$679K ﹤0.01% 2319
2013
Q4 		$14.8M Buy
858,975
+25,117
+3% +$387K ﹤0.01% 2291
2013
Q3 		$11M Buy
833,858
+11,563
+1% +$136K ﹤0.01% 2354
2013
Q2 		$9.28M Buy
+822,295
New +$8.75M ﹤0.01% 2360

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Vanguard Group's ANGO Position: Q4 2025 in Review

Vanguard Group increased its AngioDynamics (ANGO) stake by 3.1% in Q4 2025, buying an estimated $897K and bringing the position to 2,436,833 shares worth $31.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Vanguard Group first reported a position in ANGO in Q2 2013 and has held it in 51 quarters since. The position peaked at $70.6M in Q4 2021. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • Vanguard Group held 2,436,833 shares of AngioDynamics worth $31.3M as of Q4 2025.
  • Vanguard Group bought 72,687 AngioDynamics shares in Q4 2025, an estimated $897K.
  • AngioDynamics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2417 holding.
  • Vanguard Group first reported a position in AngioDynamics in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's AngioDynamics position peaked at $70.6M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.